The Israel-based company is focused on treating peripheral vascular disease by endovascular approach, with a new atherectomy device in development for multiple morphologies such as calcium, plaque or thrombus. Their first technology, the ByCross device, restores blood flow in chronic total occlusion (CTO) without the need of a guide wire, providing an alternative to bypass surgeries. Taryag Medical invites clinical experts and designers to develop more innovative technologies for overcoming challenges in vascular disease care. For more information, visit their website or contact them directly.